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SUMMARY
The Tead family transcription factors are the major
intracellular mediators of the Hippo-Yap pathway.
Despite the importance of Hippo signaling in tumori-
genesis, Tead-dependent downstream oncogenic
programs and target genes in cancer cells remain
poorly understood. Here, we characterize Tead4-
mediated transcriptional networks in a diverse
range of cancer cells, including neuroblastoma,
colorectal, lung, and endometrial carcinomas. By
intersecting genome-wide chromatin occupancy an-
alyses of Tead4, JunD, and Fra1/2, we find that
Tead4 cooperates with AP1 transcription factors to
coordinate target gene transcription. We find that
Tead-AP1 interaction is JNK independent but en-
gages the SRC1–3 co-activators to promote down-
stream transcription. Furthermore, we show that
Tead-AP1 cooperation regulates the activity of the
Dock-Rac/CDC42 module and drives the expression
of a unique core set of target genes, thereby directing
cell migration and invasion. Together, our data unveil
a critical regulatorymechanismunderlying Tead- and
AP1-controlled transcriptional and functional out-
puts in cancer cells.
INTRODUCTION
The Tead family transcription factors are a family of evolutionary
conserved proteins carrying a TEADNA binding domain that rec-
ognizes the 50-GGAATG-30 consensus sequence (Kaneko and
DePamphilis, 1998; Pobbati and Hong, 2013). Scalloped (Sd) is
the only Tead family protein in Drosophila (Halder et al., 1998;
Wu et al., 2008a). In mammals, four Tead family members,
Tead1–4, were originally identified by their various roles in early
embryonic development (Chen et al., 1994; Nishioka et al.,
2008; Sawada et al., 2008). Tead proteins require additional tran-
scriptional co-activators to activate transcription, and recent
studies have established the Yes-associated protein (YAP) fam-
ily transcriptional regulators (Yki in fly and YAP/TAZ in mammals)
as the major co-activator for Tead proteins (Nishioka et al., 2008;
Wu et al., 2008a; Zhang et al., 2009a; Zhao et al., 2008), although
other Tead upstream regulators have been reported (Gupta
et al., 1997; Halder et al., 1998; Pobbati et al., 2012). YAP and
TAZ are the key intracellular effectors of Hippo signaling, and
dysregulation of the Hippo-YAP/TAZ pathway has been impli-
cated in a variety of human cancers (Halder and Camargo,
2013; Hong and Guan, 2012; Moroishi et al., 2015; Pan, 2010).
Despite the potential importance of Tead proteins in tumori-
genesis, the molecular mechanism underlying Tead-mediated
transcriptional regulation is not well understood and the Tead-
controlled downstream target network in cancer cells remains
poorly characterized.
RESULTS
Functional Requirement and Genomic Occupancy of
Tead Proteins in Neuroblastoma, Lung, Colon, and
Endometrial Cancer Cells
To gain insight into Tead-dependent oncogenic programs, we
first examined the expression of Tead proteins in four distinct
types of human cancers: lung adenocarcinoma, colorectal carci-
noma, endometrial cancer, and neuroblastoma. Immunohisto-
chemistry (IHC) revealed that nuclear Tead4 expression was
readily detected in all four cancer types (Figure 1A). Although
mis-regulation of the Hippo-YAP pathway in lung, colon, and
endometrial cancers has been previously reported (Moroishi
et al., 2015; Tsujiura et al., 2014), its connection to neuroblas-
toma, a common infant and childhood tumor arising from the
neural crest lineage (Louis and Shohet, 2015), was not known.
We found that Tead4 was highly expressed in the majority of
human neuroblastoma samples we examined, in comparison
to low or no expression in normal peripheral nerve tissues (Fig-
ure 1A; Figure S1), pointing to a potential Tead involvement in
neuroblastoma pathogenesis. Tead4 and overall Tead proteins,
detected by the Tead4 and pan-Tead antibodies, respectively,
exhibited distinct expression patterns in human A549 (lung
adenocarcinoma), HCT116 (colon cancer), SK-N-SH (neuroblas-
toma), and ECC1 (endometrial cancer) cells (Figure 1B), suggest-
ing potential functional redundancy among Tead proteins in
cancer cells. To block the activity of all Tead proteins, we gener-
ated lentiviral-based constructs, Tead1–4 knockdown/knockout
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(Teads KD/KO), which enable both shRNA-mediated knock-
down of human Tead1, Tead3, and Tead4 (Zhao et al., 2008)
and Crispr-mediated knockout (KO) of human Tead2 (Figure 1C;
Figure S1). Furthermore, we showed that Teads KD/KO effec-
tively blocked YAP/TAZ-induced transcriptional activation and
inhibited the ability of A549, HCT116, SK-N-SH, and ECC1 cells
to form an anchorage-independent colony (Figures 1D and 1E),
highlighting the critical functional requirement for Tead proteins
in these cancer cells.
Next, we performed the analysis of genome-wide Tead4 chro-
matin immunoprecipitation sequencing (ChIP-seq) datasets
of A549, HCT116, SK-N-SH, and ECC1 cells that are available
Figure 1. Functional Requirement and Genomic Occupancy of Tead Proteins in A549, HCT116, SK-N-SH, and ECC1 Cancer Cells
(A) Representative IHC images of Tead4 staining showing nuclear expression of Tead4 proteins in human lung adenocarcinoma, colorectal carcinoma, endo-
metrial cancer, and neuroblastoma.
(B) Expression of YAP, TAZ, and Tead factors in A549, HCT116, SK-N-SH, and ECC1 cells. Immunoblot analysis of YAP, TAZ, Tead4, and overall Tead (pan-Tead)
protein expression used the antibodies against YAP, TAZ, Tead4, and pan-Tead.
(C) Immunoblot analysis of overall Tead (pan-Tead) protein and Tead2 expression in HCT116 cells expressing shRNA against Tead1, Tead3, and Tead4 (shTead1/
3/4); Crispr-mediated Tead2 KO construct (Crispr-Tead2); or both (Teads KD/KO).
(D) Teads KD/KO blocks YAP- or TAZ-induced Tead-Luc reporter activity in HEK293T cells and Tead-dependent transcriptional activity and colony formation in
A549, HCT116, SK-N-SH, and ECC1 cells.
(E) Representative images of anchorage-independent colony formation in control and Teads KD/KO-expressing HCT116 cells.
(F) Venn diagram showing overlapping of Tead4 binding sites in A549, HCT116, SK-N-SH, and ECC1 cells identified by Tead4 ChIP-seq.
(G) ChIP-qPCR analysis of selected Tead4 binding sites in the known target genes and the genes involved in pathway feedback regulation. Mean fold enrichment
in ChIP is expressed relative to a control b-actin genomic region. Sites are named according to the nearest locus.
(H) The qPCR analysis of the known YAP target genes, ANKRD1, CTGF, and Cyr61, as well as the target genes involved in pathway feedback regulation in
HCT116 cells with and without Teads KD/KO.
(I) Enrichment of AP1 motif on Tead4-occupied cis-regulatory regions in the genomes of A549, HCT116, SK-N-SH, and ECC1 cells. De novo motif analysis of
Tead4 binding sites revealed the presence of the two most enriched motifs of Tead and AP1 in all four genomes.
*p < 0.01, error bars indicate mean ± SD. See also Figures S1 and S2 and Table S1.
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at the ENCODE project (http://genome.ucsc.edu/ENCODE/
downloads.html). After intersecting the Tead4 ChIP-seq data
from these four cancer cell lines (Figure 1F; Table S1), we found
that in addition to the known direct YAP target genes, CTGF,
Cyr61, and ANKRD1 (Dupont et al., 2011; Lai et al., 2011; Zhao
et al., 2008), many genes carrying the Tead4 binding peaks en-
coded the Hippo pathway components and regulators, such as
AmotL2, Ajuba, Tead1, and Tead4 (Figure 1G). Transcription of
many of these genes could also be modulated by Tead inhibition
(Figure 1H), suggesting an active feedback regulation of the
Hippo pathway in cancer cells.
To identify the regulatory mechanism of Tead-mediated tran-
scription, we performed de novo motif analysis of the Tead4
binding regions identified in our ChIP-seq data analysis. In addi-
tion to the core Tead motif, the activating protein-1 (AP1) motif
was always among the two most enriched sequences within
the Tead4 peaks in all four genomes (Figure 1I; Figure S2),
suggesting a possible engagement of AP1 in Tead-regulated
transcription.
AP1and Tead4Co-occupancy at cis-Regulatory Regions
of Cancer Genomes
The AP1 family transcription factor is a collection of dimeric com-
plexes composed of members of the Jun, Fos, activating tran-
scription factor, and Jun dimerization protein families and has
been implicated in a range of diseases, including cancers (Meix-
ner et al., 2010; Sarkar et al., 2011; Schonthaler et al., 2011;
Verde et al., 2007). However, the molecular mechanism under-
lying AP1 activity in tumor cells remains poorly understood.
Immunofluorescence staining and western blot analysis showed
that many AP1 proteins, including JunD, c-Jun, Fos, Fra1, and
Fra2, were expressed in the cancer cells (Figures 2A and 2B)
(data not shown), suggesting potential redundancy among AP1
proteins. Consistent with this idea, we showed that Crispr-medi-
ated KO of JunD and c-Jun only partially blocked the activity
of an AP1-controlled luciferase (AP1-Luc) reporter (Figures 2C
and 2D); however, DN-JunD was able to effectively inhibit AP1-
Luc reporter activation (Figure 2D). Dominant negative JunD
(DN-JunD) is a dominant repressor form of JunD that lacks the
N-terminal transcriptional activation domain but retains the
DNA binding domain and the ability to dimerize with other AP1
proteins, thereby inhibiting AP1 activation (Figure S1).
To explore AP1-mediated transcriptional programs in cancer
cells, we performed analysis of the JunD, Fra1, and Fra2 ChIP-
seq datasets of the A549, HCT116, and SK-N-SH genomes
from the ENCODE project (Tables S2 and S3). We then inter-
sected these data with the Tead4 ChIP-seq datasets and found
significant overlaps of Tead4 peaks with AP1 (JunD, Fra1, and
Fra2) peaks in three cell lines (Figures 2E–2G). Statistical analysis
of Tead4 peaks overlapping JunD or Fra1/2 peaks or random
genomic regions showed significant enrichment of the AP1 over-
lapping peaks with the empirical p values at 0 in all cases. More
strikingly, more than half of the Tead4 binding regions overlap-
pedwith the JunD- or Fra1/2-occupied sites in all three genomes
(Figures 2E–2G). Furthermore, we performed de novomotif anal-
ysis of the JunD and Fra1/2 peaks identified in three cell lines and
showed that the Tead motif was also among the top enriched
motifs within the JunD or Fra1/2 binding regions (Figure S2).
Thus, our analyses of both Tead4 and AP1 genome-wide
ChIP-seq data identified the intensive interactions between
Tead4- and AP1-controlled transcriptional networks in a range
of human cancer cells.
To further characterize Tead4 and AP1 genomic co-occu-
pancy, we examined the histone modification status of Tead4/
AP1 peaks in A549 cells by analysis of genome-wide
H3K4me1, H3K4me3, and H3K27ac ChIP-seq data obtained
from the ENCODE project. The Tead-AP1 peaks with histone
H3 monomethylation at lysine 4 (H3K4me1) were considered
as enhancer regions. Active enhancers were defined by the co-
presence of H3K4me1 and H3K27ac (histone H3 acetylation at
lysine 27), and promoter regions were defined as H3K4me3
(histone H3 trimethylation at lysine 4) and H3K27ac overlapping
peaks that haveminimal overlapping of 1,000 bp and are close to
a transcriptional start site (2,000 bp upstream to 500 bp down-
stream). Our analysis revealed that most Tead4-AP1 co-occu-
pied peaks were the active enhancer regions (86%), and 12%
of them were active promoters (Figures 2H and 2I). In addition,
the bimodal distribution of H3K4me1 signal around the peak
center (Figure 2J) supported the notion that these Tead-AP1
peaks were in an active state. Further analysis showed that the
Tead and AP1 binding motifs were located close to the peak
summit (Figure 2J), and the median space between them was
about 70 bp. Taken together, these data suggest that Tead
and AP1 factors may operate closely in active enhancer or pro-
moter regions to regulate downstream transcription in cancer
cells.
Tead and AP1 Coordinate Downstream Gene
Transcription
To examine Tead-AP1-mediated co-regulation of downstream
transcription, we dissected in detail the Tead4 or AP1 binding
cis-regulatory elements identified in the ANKRD1, Dock9, and
Tead4 loci (Figure 3A). Tead4 is a core Hippo component likely
involved in pathway feedback regulation (Figure 1H), and
ANKRD1 is a known YAP target gene (Dupont et al., 2011; Lei
et al., 2015); however, it was not clear whether Dock9 can be
transcriptionally regulated by Tead or AP1. The analysis of his-
tonemodification status revealed that these Tead1 or JunD bind-
ing sites were located within the active promoter (ANKRD1 and
Tead4) or active enhancer (Dock9) regions (Figure 3A). The
lack of AP1 occupancy in the peak of the Tead4 locus suggested
that its expression may be independent of AP1 (Figure 3A). We
found that YAP and TAZ short hairpin RNA (shRNA) knockdown,
but not DN-JunD expression, decreased Tead4 expression in
HCT116 cells (Figures 3C and 3D). In contrast, ANKRD1 and
Dock9 expression was significantly decreased by inhibition of
both Tead and AP1 activity (Figure 3B). Furthermore, we gener-
ated the luciferase reporter constructs driven by the promoter or
enhancer peaks identified in the ANKRD1, Dock9, and Tead4 loci
(ANK-Luc, Dock9-Luc, and Tead4-Luc, respectively). We
showed that although Tead4-Luc was only responsive to YAP
activation (Figure 3G), YAP and JunD co-expression synergisti-
cally induced reporter activation of ANK-Luc and Dock9-Luc
(Figures 3E and 3F). Together, these data suggest that YAP/
Tead-AP1 cooperation on the distal or proximal regulatory
regions regulates a subset of target gene expression.
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Figure 2. AP1 and Tead4 Co-occupancy at cis-Regulatory Regions of Cancer Genomes
(A) Immunoblot analysis of JunD, c-Jun, Fra1, and Fra2 protein expression in A549, HCT116, and SK-N-SH cells.
(B) Immunofluorescence staining of JunD and Fra1 in HCT116 cells. DAPI labels the nuclei.
(C) Immunoblot analysis of JunD and c-Jun expression in HCT116 cells with and without expression of Crispr KO constructs against JunD or c-Jun.
(D) Reporter activity of AP1-Luc in HCT116 cells with the Crispr KO constructs against JunD and c-Jun or the expression construct of DN-JunD.
(E–G) Intersection of Tead4, JunD, and Fra1/2 ChIP-seq in the A549 (E), HCT116 (F), and SK-N-SH (G) genomes, showing significant co-occupancy of Tead4 and
JunD/Fra1/2 in all three cell lines.
(H) Heatmap representing Tead4/JunD/Fra2 co-occupied peaks located within promoter or enhancer regions of the A549 genome. The heatmap is sorted by
density of Tead4 signals in each category. 0, peak center; ±1,000, 1 kb upstream or downstream of the center.
(I) Percentage of Tead4/JunD/Fra2 co-occupied peaks in the categories of active promoters (H3K4me3+;H3K27ac+), active enhancers (H3K4me1+;H3K27ac+),
and inactive enhancers (H3K4me1+;H3K27ac).
(J) Bimodal distribution of the H3K4me1 signal around the summit of the Tead4/JunD/Fra2 co-occupied peaks.
*p < 0.01, error bars indicate mean ± SD. See also Figures S1 and S2 and Tables S2 and S3.
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Figure 3. Tead and AP1 Cooperation on
Downstream Gene Transcription
(A) Diagram showing the Tead4, JunD, H3K4me3,
and H3K27ac peaks in the promoter or enhancer
regions of the ANKRD1, Dock9, and Tead4 loci of
the HCT116 genome. Scale bar, 2 kb.
(B) Immunoblot analysis of ANKRD1 and Dock9
expression in HCT116 cells with Teads KD/KO or
AP1 inhibition by DN-JunD.
(C) Immunoblot analysis of Tead4 expression in
HCT116 cells with shRNA knockdown against
YAP and TAZ (shYAP/TAZ) or AP1 inhibition by
DN-JunD.
(D) Immunoblot analysis of YAP and TAZ expres-
sion in HCT116 cells expressing shYAP/TAZ.
(E–G) Luciferase reporters driven by the Tead4
peaks from the ANKRD1, Dock9, and Tead4 loci
were generated, and the reporter activity of
ANK-Luc (E), Dock9-Luc (F), and Tead4-Luc (G) in
HEK293T cells was measured with or without
ectopic expression of JunD and YAP.
(H and I) ChIP in HCT116 cells was performed
with control immunoglobulin G (IgG), Tead4,
c-Jun, JunD, Fos, and Fra1 antibodies as indi-
cated. The enrichment of the ANKRD1 promoter
region was calculated based upon qPCR relative
to the IgG control.
(J) Sequential ChIP with antibody against Tead4
followed by antibody against JunD confirms the
presence of both transcription factors on the
ANKRD1 promoter. Enrichment is calculated
based upon qPCR relative to the no antibody
(No Ab) or IgG control.
(K) Diagrams of the wild-type ANKRD1 luciferase
(ANK-Luc) reporter and the luciferase reporters
driven by the mutated peak lacking the Tead motif
(ANK-mT-Luc) or the AP1 motifs (ANK-mA-Luc).
(L) Activity of the ANK-Luc reporter was measured
in HCT116 cells with JunD, Fra1, or both.
(M) Activity of ANK-Luc, ANK-mT-Luc, and
ANK-mA-Luc reporters was measured with YAP/
Tead4, JunD/Fra1, or both.
(N and O) JunD binds both exogenous and
endogenous Tead4 in cells. (N) Indicated plasmids
were co-transfected into HEK293T cells, and
Tead4 was immunoprecipitated with anti-V5 anti-
body. Immunoblot analysis shows coIP of JunD
detected by anti-FLAG antibody. (O) Tead4 binds
to endogenous JunD in HCT116 cells. Endoge-
nous Tead4 was immunoprecipitated with anti-
Tead4 antibody, and coIP of JunD and YAP was
shown by anti-JunD and anti-YAP immunoblots.
A control IgG was used as the negative control for
immunoprecipitation.
*p < 0.01, error bars indicate mean ± SD.
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Our ChIP-qPCR analysis showed that Tead4 and various AP1
proteins, including JunD, c-Jun, Fos, and Fra1, were able to bind
to the peak located in the ANKRD1 promoter (Figures 3H and 3I).
The co-occupancy of Tead4 and AP1 was confirmed by sequen-
tial re-ChIP experiments (Figure 3J). Furthermore, we generated
the ANK-Luc-based reporter constructs with a mutated Tead
or AP1 binding site (ANK-mT-Luc or ANK-mA-Luc, respectively)
(Figure 3K). When JunD and Fra1 were co-expressed, the JunD/
Fra1 heterodimer strongly induced ANK-Luc reporter activity
(Figure 3L). However, expression of Tead4 alone with JunD/
Fra1 did not further enhance reporter activity (data not shown),
suggesting that unlike YAP, AP1 is not able to activate Tead pro-
teins. In contrast, when Tead4 was activated by YAP, it acted
synergistically with JunD/Fra1 to promote wild-type ANK-Luc
reporter activity (Figure 3M). Furthermore, although YAP/Tead4
or JunD/Fra1 was capable of activating AP1 site-mutated
or Tead site-mutated luciferase reporters, respectively, YAP/
Tead4 and JunD/Fra1 lost the ability to synergize with each other
(Figure 3M), suggesting that YAP/Tead and AP1 proteins do not
rely on each other to bind to the cis-regulatory region but rather
act synergistically to achieve maximum transcriptional output.
We also detected JunD and Tead4 protein-protein interactions
exogenously in transfected HEK293T cells (Figure 3N) and
endogenously in HCT116 cells (Figure 3O). Our co-immunopre-
cipitation (coIP) assays detected Tead4 binding to endogenous
YAP or AP1 proteins, including JunD, c-Jun, and to a lesser
degree, Fos (Figure 3O) (data not shown). However, we could
not detect strong interaction between YAP and AP1 proteins
by YAP and AP1 coIP (data not shown), further suggesting the
interaction occurs at the level of the Tead and AP1 transcription
factors.
Tead and AP1 Interaction Is JNK Independent
To explore themolecular mechanism underlying Tead-AP1 inter-
action, we first examined the possible involvement of c-Jun
amino-terminal kinases (JNKs). The activity of AP1 proteins
can be regulated via N-terminal phosphorylation by upstream
JNKs (Davis, 2000). Recent reports also showed that JNK can
modulate Hippo/YAP signal transduction in certain contexts
(Lee and Yonehara, 2012; Sun and Irvine, 2013; Tomlinson
et al., 2010). Therefore, we sought to test whether Tead-AP1
cooperation depends on JNK activity in cancer cells. We used
a recently developed, highly specific JNK inhibitor, JNK-IN-8
(Zhang et al., 2012), and showed that JNK-IN-8 treatment of
HCT116 or A549 cells was able to effectively block c-Jun phos-
phorylation but not large tumor suppressor kinase (Lats)-
mediated YAP phosphorylation (Figure 4A) (data not shown).
JNK inhibition also did not alter YAP cellular localization or the
expression of the YAP target genes, CTGF and ANKRD1 (Fig-
ure 4B; Figure S3). Furthermore, JNK inhibition or activation by
overexpression of a MKK7-JNK construct did not affect Tead-
AP1 interaction or transcriptional cooperation, measured by
Tead/JunD coIP and ANK-Luc reporter activity (Figure 4C;
Figure S3). In addition, we showed that c-Jun4A, a mutant
form of c-Jun with all four N-terminal JNK phosphorylation sites
mutated, was as efficient to induce ANK-Luc reporter activation
as wild-type c-Jun (Figure S3). These results indicated that JNK
phosphorylation does not likely play a major role in regulating
Tead-AP1 functional interaction, and either an additional or a
different mechanism is involved.
Tead-AP1 Cooperation Engages SRC1–3 Co-activators
The p160 family of steroid receptor co-activators, SRC1–3 (also
known as NCOA1–3), were originally identified as nuclear hor-
mone co-activators (Xu et al., 2009), although it was later discov-
ered that they can interact with a range of other transcriptional
factors, including AP1 proteins, to regulate gene transcription
(Lee et al., 1998; Qin et al., 2014; Xu et al., 2009; Yan et al.,
2006). A previous report identified all three SRCs as Tead bind-
ing partners through a yeast two-hybrid screen and showed
they can potentiate Tead-mediated transcription (Belandia and
Parker, 2000). However, the cellular context and function of
this interaction were not clear. Our immunofluorescence and
immunoblot analyses revealed that SRC proteins were ex-
pressed in A549, HCT116, SK-N-SH, and ECC1 cancer cells
(Figures 4D and 4E) (data not shown). More importantly, we
demonstrated the binding of endogenous SRC3, JunD, and
Tead4 in HCT116 cells (Figure 4F). To further characterize the
interactions among these proteins, we generated the expression
constructs of three truncated mutants of SRC3 fused with a
C-terminal V5 tag: SRC3-N, SRC3-M, and SRC3-C (Figure 4G).
We then examined their ability to bind to endogenous Tead4
and JunD proteins using the coIP assay. Consistent with the pre-
vious report (Belandia and Parker, 2000), we showed that SRC3
interacted with Tead4 through its N-terminal basic-helix-loop-
helix (bHLH)-PAS domain (Figure 4H). We found that the SRC3
domain responsible for JunD binding was mainly located in its
C terminus (Figure 4H). These data raised an intriguing possibility
that SRC factors bridge the interaction between Tead and AP1,
thereby mediating their cooperation.
Consistent with this idea, our SRC3 ChIP-qPCR analysis
revealed that SRC3 was significantly more enriched at the
ANKRD1 peak with Tead and AP1 co-occupancy than at the
Tead4 peak with only Tead occupancy (Figure 4I). To further
examine the importance of SRC proteins in Tead-AP1 coopera-
tion, we generated the Crispr-based constructs to knock out all
three SRC proteins in HCT116 cells (Figure 4J). In addition, we
used a recently identified SRC1/3 specific inhibitor, Bufalin
(Figure 4K) (Wang et al., 2014). We found that inhibition of SRC
function by SRC1–3 Crispr KO or Bufalin treatment did not affect
Tead4 protein expression (Figure 4K) or Tead-Luc reporter activ-
ity induced by YAP5SA, a constitutively active form of YAP (Fig-
ure 4L) (Zhao et al., 2008). However, we found that SRC inhibition
significantly blocked the endogenous Tead-JunD interaction
(Figure 4M) and inhibited the synergistic effect on ANK-Luc
reporter activation by YAP/Tead-JunD/Fra1 co-expression (Fig-
ure 4N). Taken together, these studies suggested that Tead-AP1
cooperation is mediated at least in part by the SRC1–3 co-
activators.
Tead-AP1Drives a Core Set of Target Genes to Regulate
Migration and Invasion
Our analysis of Tead4 ChIP-seq in a range of cancer cells iden-
tified the previously known YAP/Tead targets, including CTGF,
Cyr61, Axl, Birc5, and AREG, involved in regulation of pro-
liferation and apoptosis (Dong et al., 2007; Lai et al., 2011;
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Xu et al., 2011; Zhang et al., 2009b; Zhao et al., 2008). How-
ever, it was not clear whether the cooperation between YAP/
Tead and AP1 drives additional function or distinct targets in
cancer cells.
To explore potential downstream transcriptional programs
controlled by Tead and AP1, we performed functional clustering
analysis of the overlapping genes with Tead4, JunD, and Fra1/2
peaks from A549, HCT116, and SK-N-SH cells (Figure 5A). By
Figure 4. JNK-Independent AP1-Tead
Interaction Engages SRC1–3 Co-activators
(A) Immunoblot analysis of c-Jun, phosphorylated
c-Jun (p-cJun), YAP, and phosphorylated YAP
(p-YAP) in HCT116 cells with or without the JNK
inhibitor JNK-IN-8.
(B) A qPCR analysis of CTGF and ANKRD1
transcription in HCT116 cells with or without
JNK-IN-8.
(C) JNK inhibition or activation does not
affect Tead/AP1 cooperation. Activity of the
ANK-Luc reporter induced by JunD/Fra1 and
YAP/Tead4 was measured with the pres-
ence of JNK-IN-8 or the expression of
MKK7-JNK.
(D) Immunofluorescence staining of SRC1 in
HCT116 cells. DAPI labels the nuclei of HCT116
cells.
(E) Expression of SRC1 and SRC3 proteins
in A549, HCT116, SK-N-SH, and ECC1 cells, as-
sayed by immunoblotting.
(F) SRC3 binds to endogenous JunD and
Tead4 in HCT116 cells. Endogenous SRC3
was immunoprecipitated with anti-SRC3 anti-
body, and coIP of JunD and Tead4 was
shown by anti-JunD and anti-Tead4 immuno-
blots. A control immunoglobulin G (IgG) was
used as the negative control for immunoprecip-
itation.
(G) Diagrams of wild-type and truncated
SRC3 constructs with a C-terminal V5 tag.
Indicated are the bHLH-PAS domain, the
nuclear receptor interacting domain (RID), and
activation domains 1 and 2 (AD1 and AD2,
respectively) in SRC3, SRC3-N, SRC3-M, and
SRC3-C.
(H) In HCT116 cells expressing wild-type
and truncated SRC3 proteins, immunoprecipi-
tation was performed with anti-V5 antibody, and
coIP of endogenous Tead4 and JunD was
shown by anti-Tead4 and anti-JunD immuno-
blots.
(I) ChIP from HCT116 cells was performed with
control IgG or the SRC3 antibody as indicated.
The enrichment of the ANKRD1 and Tead4 peak
was calculated based upon qPCR relative to the
IgG control.
(J) Immunoblot analysis of SRC1, SRC2, and
SRC3 in HCT116 cells with or without expression
of Crispr KO constructs against SRC1, SRC2, and
SRC3 (SRC1–3 KO).
(K) Immunoblot analysis of SRC1, SRC3, and
Tead4 in HCT116 cells with or without the SRC1/3
inhibitor, Bufalin.
(L) Activity of the Tead-Luc reporter induced by
YAP5SA in HEK293T cells with or without SRC1–3
Crispr KO or Bufalin treatment.
(M) In HCT116 cells with SRC1–3 Crispr KO or Bufalin treatment, endogenous JunD was immunoprecipitated with anti-JunD antibody and coIP of endogenous
Tead4 was shown by anti-Tead4 immunoblots.
(N) In HCT116 cells expressing SRC1–3 KO, reporter activity of ANK-Luc was measured with YAP/Tead4, JunD/Fra1, or both.
*p < 0.05, **p < 0.01, error bars indicate mean ± SD. See also Figure S3.
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comparing the functional clustering data between the genes with
the Tead4 peaks and the genes with Tead4/AP1 co-occupied
peaks, we found significant enrichment of the clusters associ-
ated with cell adhesion, motility, and migration within the genes
carrying the Tead/AP1 co-occupied peaks (Table 1), suggesting
a potential regulation of cell migration and invasion by Tead-AP1.
In addition, Tead4, JunD, and Fra1/2 often bound to the distal or
proximal regulatory regions of the genes encoding the Dock pro-
teins (Tables S1, S2, S3, and S4). Dock is a family of 11 related
proteins functioning as the specific guanine nucleotide ex-
change factors for the small G proteins Rac and Cdc42 that
play a pivotal role in orchestrating cell adhesion and movement
(Laurin and Co^te´, 2014). Our qPCR and immunoblot analyses
in HCT116 cells showed that transcription and expression of
many Dock factors, including Dock4, Dock5, and Dock9, were
downregulated by inhibition of both AP1 and Tead activation
(Figures 3B, 5C, and 5E; Figure S4). Moreover, we found that
the activity of Rac1 and CDC42, but not the protein levels, was
significantly decreased following Tead and AP1 inhibition (Fig-
ures 5D and 5E). In contrast, the activity and expression of
RhoA, the other member of the Rho small G protein family,
were largely unaffected (Figures 5D and 5E). These data sug-
gested that Tead and AP1 act as important upstream regulators
for the Dock-Rac/CDC42 functional module in cancer cells.
In addition to the Dock-Rac/CDC42 axis, our functional anno-
tation revealed that more than 50 of the 300 genes with Tead and
AP1 co-occupied peaks were directly implicated in regulation of
cell migration and invasion (Table S4). Among them, we found
that transcription of ABL2, CDH2, CNN3, DAAM1, GRP126,
ITBG5, MACF1, MKLN1, NRP1, PARD3, PHLDB2, and TNS3
was inhibited by blocking Tead and AP1 activity in HCT116 cells
(Figure 5B; Figure S4), suggesting that these genes represent a
core set of new direct targets of Tead and AP1 in cancer cells.
Moreover, these results support the idea that a key functional
output of YAP/Tead-AP1 cooperation is to regulate cancer cell
migration and invasion.
To test this hypothesis, we ectopically expressed YAP5SA and
JunD in the HT29 cells, a relatively less invasive colon cancer cell
line (de Both et al., 1999), and found that YAP5SA and JunD co-
expression significantly promoted migration of HT29 cells, as
measured by transwell migration assay (Figure 5F). In addition,
we showed that migration induced by YAP5SA or TAZ4SA (an
active form of TAZ) was partially inhibited by DN-JunD (Fig-
ure 5G). Furthermore, we found that Crispr-mediated SRC1–3
KO or Dock4 and Dock9 KO inhibited YAP5SA/JunD-dependent
Figure 5. Tead and AP1 Drive a Core Set of Downstream Targets to Regulate Cell Migration and Invasion
(A) Venn diagram showing the overlapping Tead4, JunD, and Fra1/2 peaks identified by ChIP-seq in A549, HCT116, and SK-N-SH genomes.
(B) A qPCR analysis of the transcription of selected target genes involved in the regulation of cell migration and invasion in HCT116 cells with Teads KD/KO and
AP1 inhibition by DN-JunD.
(C) A qPCR analysis of the transcription of Dock4, Dock5, and Dock9 in HCT116 cells with Teads KD/KO or AP1 inhibition by DN-JunD.
(D) Measurement of the activity of the Rho family small G proteins, RhoA, RAC1, and CDC42, in HCT116 cells with Teads KD/KO or AP1 inhibition by DN-JunD.
(E) Immunoblot analysis of DOCK4, RAC1, and CDC42 in HCT116 cells expressing DN-JunD, Teads KD/KO, or both.
(F) Representative images of transwell migration of HT29 cells with ectopic expression of JunD, YAP5SA, or both.
(G) Relative migration activity of HT29 cells expressing YAP5SA or TAZ4SA with or without DN-JunD.
(H) Immunoblot analysis of Dock4 and Dock9 in HCT116 cells expressing Crispr KO constructs against Dock4 and Dock9 (Dock4/9 KO).
(I) Representative images of transwell migration of YAP5SA/JunD-expressing HT29 cells with SRC1–3 or Dock4/9 KO.
(J) Quantification of the transwell migration assay shown in (I).
(K) Representative images of the cell scratch assay of HCT116 cells expressing DN-JunD or Teads KD/KO at 0 or 48 hr.
(L) Representative images of the matrigel invasion assay in control (i) or HCT116 cells expressing DN-JunD (ii), Teads KD/KO (iii), or both (iv).
(M) Quantification of the matrigel invasion assay shown in (L).
(N–Q) Co-expression of JunD and Tead4 proteins in human lung adenocarcinomas (n = 30) and matched lymph node metastases (n = 30) by tissue microarray
assays. (N) Representative IHC images of nuclear expression of JunD and Tead4 in lymph nodemetastases of lung adenocarcinoma. (O and P) Higher expression
of JunD (O) and Tead4 (P) in lymph node metastases in comparison to matched primary lung adenocarcinoma samples. (Q) The percentage of co-expression of
high-level JunD and Tead proteins in primary lung adenocarcinoma and matched lymph node metastases. P, primary lung adenocarcinoma; M, matched lymph
node metastases.
*p < 0.05, **p < 0.01, error bars indicate mean ± SD. See also Figure S4 and Table S4.
Table 1. Functional Clustering of the Overlapping Genes
Carrying Tead4 Peaks or Tead/AP1 Co-occupied Peaks from
A549, HCT116, and SK-N-SH Cells
Tead4 Peaks Tead-AP1 Peaks
blood vessel morphogenesis blood vessel morphogenesis
transcription activator activity focal adhesiona
regulation of transcription regulation of cell adhesiona
regulation of kinase activity cell-cell adhesiona
regulation of cell motiona cell migrationa
pattern specification process regulation of kinase activity
lung development regulation of protein
modification process
focal adhesiona cytoskeletal protein binding
chordate embryonic
development
regulation of cell motiona
regulation of protein
modification process
regulation of cell growth







transforming growth factor b
receptor binding
actin cytoskeleton organizationa
growth factor binding guanosine triphosphatase
activation
regulation of cell growth embryonic morphogenesis
aFunctional clusters associated with cell motility.
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migration in HT29 cells (Figures 5H–5J), highlighting the func-
tional importance of these proteins in YAP/Tead-AP1 coopera-
tion. Next, we demonstrated that the combined inhibition of
Tead and AP1 activity in the highly invasive HCT116 colon can-
cer cells (de Both et al., 1999) led to effective inhibition of cell
migration and invasion, measured by cell scratch and matrigel
invasion assays (Figures 5K–5M). Moreover, we analyzed the
expression of JunD and Tead4 in 62 human lung adenocarci-
nomas and their matched lymph node metastases and found
that JunD and Tead4 proteins were expressed significantly
higher in the lymph node metastases than in the matched pri-
mary cancers (Figures 5N–5Q), suggesting the potential involve-
ment of Tead-AP1 cooperation in promoting tumor invasion and
metastasis.
DISCUSSION
By intersecting the transcriptional networks employed by both
Tead4 and AP1 proteins in diverse cancer cells, we uncovered
a critical mechanism underlying Tead- and AP1-mediated onco-
genic regulation. Our data support a model that Tead and AP1
interaction at theactivecis-regulatory genomic regionspromotes
or maximizes transcription output of target genes (Figure 6). The
Tead-AP1 cooperation we described here is distinct from the
recently reported Tead-independent Fos regulation by Kras and
YAP in pancreatic cancer cells (Shao et al., 2014). However, our
data are consistent with a recent report of Tead and AP1 co-oc-
cupancy on cis-regulatory regions in the invasive melanoma
genome (Verfaillie et al., 2015). Furthermore, during the revision
of this manuscript, a recent study described the genomic associ-
ation between YAP/TAZ/Tead andAP1 in breast cancer cells that
drives oncogenic growth (Zanconato et al., 2015).Our analysesof
both AP1 and Tead4 genome-wide ChIP-seq data in a range of
tumor cells, including neuroblastoma, colon, lung, and endome-
trial cancers, suggest that Tead-AP1 cooperation on transcrip-
tion is a generalmechanismused by both families of transcription
factors during tumorigenesis.
Recent reports showed the possible JNK regulation of Hippo
signaling via upstream Lats kinases or direct phosphorylation
of YAP in fly and mammalian cells during apoptosis (Lee and Yo-
nehara, 2012; Sun and Irvine, 2013; Tomlinson et al., 2010). How-
ever, our data indicate that Tead-AP1 cooperation in cancer cells
does not appear to require JNK phosphorylation, highlighting the
complex crosstalks between these pathways in different func-
tional and cellular contexts. More importantly, our study revealed
a key molecular mechanism underlying Tead-AP1 interaction
that is mediated by the SRC1–3 transcriptional co-factors (Fig-
ure 6). The SRC1–3 family transcriptional co-activators, originally
identified as nuclear receptor co-regulators, have been shown to
interact with a variety of transcription factors. Our study suggest
a model in which Tead and AP1 co-occupancy at the promoter
and active enhancer regions engages SRC factors, which bind
to Tead and AP1 through distinct N-terminal and C-terminal
domains to bridge the Tead-AP1 interaction, thereby mediating
at least in part their cooperation on downstream transcription
in cancer cells (Figure 6).
Current knowledge of the YAP/Tead downstream targets
in cancers has been largely focused on the genes, such as
CTGF, Cyr61, Birc5, AXL, and AREG, that are involved in regula-
tion of proliferation, apoptosis, and oncogenic growth (Dong
et al., 2007; Lai et al., 2011; Xu et al., 2011; Zanconato et al.,
2015; Zhang et al., 2009b; Zhao et al., 2008). Our results not
only identified a core subset of downstream YAP/Tead target
genes but also uncovered a critical functional output of Tead-
AP1 in coordination of cell migration and invasion in diverse
types of cancer cells (Figure 6). These Tead and AP1 down-
stream targets include members of the Dock family proteins
and other genes such as CDH2,MACF1, ABL2, and TNS3, which
all have been directly implicated in controlling different aspects
of cell motility, including cytoskeleton organization, cell adhe-
sion, and migration (Bradley and Koleske, 2009; Laurin and
Co^te´, 2014; Qian et al., 2009; Wu et al., 2008b). Recent studies
have reported that cell attachment, cell-matrix interaction, and
mechanical forces can influence upstream Hippo signaling
converging on YAP/TAZ regulation (Chang et al., 2015; Dupont
et al., 2011; Halder et al., 2012; Zhao et al., 2012). Our study
suggests the importance of the interplay and possible feed-
back regulation between Tead-AP1 activation and cell adhesion,
migration, and invasion during tumorigenesis and metastasis.
EXPERIMENTAL PROCEDURES
Cell Culture, Transfection, and Lentiviral Infection
HCT116, SK-N-SH, ECC1, FET, DLD1, LS174T, and HEK293T cells were
cultured in DMEM supplemented with 10% fetal bovine serum (FBS). A549
cells were cultured in F-12K medium supplemented with 10% FBS. HT29 cells
were cultured in McCoy 5A medium supplemented with 10% FBS. Caco2 and
RKO cells were cultured in Eagle’s minimal essential medium supplemented
with 20% FBS. SW48 cells were cultured in L15 medium supplemented
with 10% FBS. Detailed information of lentiviral expression vectors, Crispr
KO or shRNA knockdown constructs, and luciferase reporter constructs are
described in Supplemental Experimental Procedures.
Cell and Biochemical Assays
For IHC, human cancer tissue microarray samples were purchased from Bio-
max, Genvelop, or the University of Massachusetts Cancer Center Tissue
Bank. Antibody information for IHC, immunofluorescence, and immunoblot
analyses are shown in Supplemental Experimental Procedures. Detailed
protocols for assaying cell migration and invasion, anchorage-independent
Figure 6. YAP/Tead-AP1 Cooperation on cis-Regulatory Regions
Regulates Migration and Invasion
A schematic model showing YAP/Tead-AP1 cooperation on cis-regulatory
regions engages SRC1–3 co-activators and drives downstream gene
expression to regulate cancer cell migration and invasion.
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colony formation, ChIP, protein immunoprecipitation, and small G protein acti-
vation are also described in Supplemental Experimental Procedures.
ChIP-Seq, De Novo Motif Discovery, and Functional Clustering
Analyses
Tead4, JunD, Fra1, Fra2, H3K4me1, H3K4me3, and H3K27ac ChIP-seq data
were obtained from the ENCODE project, and data analysis and de novo motif
discovery were performed using Homer software (http://homer.salk.edu/
homer/). Functional clustering analysis was done using DAVID v.6.7 (https://
david.ncifcrf.gov/). Additional details are provided in Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and five tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2015.12.104.
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